Observational studyFrontiers in immunology2024

Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study.

Chun-Xia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.